Could a simple drink catch hidden diabetes?
NCT ID NCT07233434
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This pilot study in Guadeloupe is testing whether an oral glucose tolerance test (OGTT) can find type 2 diabetes in people of African or Indian origin who have normal fasting blood sugar but other risk factors. About 120 adults will take the test and be followed for a year. The goal is to see if this method catches diabetes that standard screening misses.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
oral glucose tolerance test (OGTT)
What this could lead to
If successful, this could show that adding an oral glucose test improves early diabetes detection in specific populations, leading to better screening guidelines.
What could go wrong
This is a small pilot study (120 people) in one region, so results may not apply broadly. The test is not a treatment and carries no direct benefit to participants.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-DIABETIC are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Centre Hospitalier Universitaire de la Guadeloupe
RECRUITINGPointe-à-Pitre, Guadeloupe, 97159, Guadeloupe
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••